BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24858368)

  • 1. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.
    Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S
    Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by acetylcholine: a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway.
    Sun L; Zhao M; Yu XJ; Wang H; He X; Liu JK; Zang WJ
    J Cell Physiol; 2013 Jun; 228(6):1238-48. PubMed ID: 23139024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis.
    Dong F; Li Q; Sreejayan N; Nunn JM; Ren J
    Diabetes; 2007 Sep; 56(9):2201-12. PubMed ID: 17575086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
    Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
    Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
    Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
    Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.
    Wang Y; Zhao X; Lotz M; Terkeltaub R; Liu-Bryan R
    Arthritis Rheumatol; 2015 May; 67(8):2141-53. PubMed ID: 25940958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
    Yan W; Zhang H; Liu P; Wang H; Liu J; Gao C; Liu Y; Lian K; Yang L; Sun L; Guo Y; Zhang L; Dong L; Lau WB; Gao E; Gao F; Xiong L; Wang H; Qu Y; Tao L
    Basic Res Cardiol; 2013 May; 108(3):329. PubMed ID: 23460046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PGC-1α-Mediated Transcriptional Network Maintains Mitochondrial Redox and Bioenergetic Homeostasis against Doxorubicin-Induced Toxicity in Human Cardiomyocytes: Implementation of TT21C.
    Yuan H; Zhang Q; Guo J; Zhang T; Zhao J; Li J; White A; Carmichael PL; Westmoreland C; Peng S
    Toxicol Sci; 2016 Apr; 150(2):400-17. PubMed ID: 26781513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner.
    Russell LK; Mansfield CM; Lehman JJ; Kovacs A; Courtois M; Saffitz JE; Medeiros DM; Valencik ML; McDonald JA; Kelly DP
    Circ Res; 2004 Mar; 94(4):525-33. PubMed ID: 14726475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
    Rong J; Li L; Jing L; Fang H; Peng S
    Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
    Yu JL; Jin Y; Cao XY; Gu HH
    Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
    Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
    Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.
    Saleh MF; Elsayad ME; Goda AE
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6573-6584. PubMed ID: 34787860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway.
    Yin J; Guo J; Zhang Q; Cui L; Zhang L; Zhang T; Zhao J; Li J; Middleton A; Carmichael PL; Peng S
    Toxicol In Vitro; 2018 Sep; 51():1-10. PubMed ID: 29729358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E confers cytoprotective effects on cardiomyocytes under conditions of heat stress by increasing the expression of metallothionein.
    Wang X; Dong W; Yuan B; Yang Y; Yang D; Lin X; Chen C; Zhang W
    Int J Mol Med; 2016 May; 37(5):1429-36. PubMed ID: 27035111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
    Wang GW; Klein JB; Kang YJ
    J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity.
    Jing L; Wu Y; Wu J; Zhao J; Zuo D; Peng S
    Eur J Pharmacol; 2011 Jun; 659(2-3):224-32. PubMed ID: 21463615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
    Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
    Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment.
    Guo Q; Guo J; Yang R; Peng H; Zhao J; Li L; Peng S
    Oxid Med Cell Longev; 2015; 2015():151972. PubMed ID: 26075032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.